Announced that The Brazilian regulatory agency ANVISA has approved the commencement of additional Phase 3 clinical trials of Leronlimab in certain Novel Coronavirus-19 patients. The trial will focus on hospitalized critically ill patients requiring mechanical and invasive ventilation or extracorporeal membrane oxygenation.$CYTODYN INC (CYDY.US)$
CYTODYN INC Stock Forum
The trial will focus on hospitalized critically ill patients requiring mechanical and invasive ventilation or extracorporeal membrane oxygenation. $CYTODYN INC (CYDY.US)$
No comment yet